Table of Contents
Lord’s Mark Industries Unlisted Share
BUY
N/A
SELL
N/A
Lords Mark Industries shares may be in a downtrend due to several factors, including potential supply exceeding demand in the market, the unlisted nature of the shares, and concerns about the company's financial performance. These factors can lead to lower liquidity, price volatility, and regulatory risks for investors.
As on 29 Jul 2026, 04:58 PM, we are buying shares of the N/A for N/A and selling them for N/A per share.
About Lord’s Mark Industries Unlisted Share
Lords Mark Group, established in 1998 as a paper business, has evolved into a diversified conglomerate. Today, the group focuses on high-growth sectors—primarily In-Vitro Diagnostics (IVD), MedTech, and Renewable Energy.
With a strategic shift away from legacy businesses, Lords is actively divesting its paper division and planning a reverse merger to enter the listed space, signaling aggressive expansion and transformation.
Read more
Business Divisions
a) IVD / MedTech Division
-
Focused on rapid diagnostics and non-communicable disease management
-
Portfolio includes 34+ rapid test kits, surgical consumables, and biochemicals
-
Expanding into genome testing and B2C with E-smart clinics
b) Renewable Energy / LED Division
-
Market leader in rooftop solar installations in UP and Bihar
-
Strategic partnerships with Philips and defense projects
-
500 MW solar project target over 7 years; current order book: ₹2,000+ Cr
c) Paper Division (To Be Divested)
-
Currently contributes 18% of revenue
-
Planned divestment to focus on high-growth MedTech and solar verticals
Financial Highlights (FY22–FY24)
1. Revenue Growth:
Revenue surged from ₹213 Cr (FY22) to ₹555 Cr (FY24), indicating a CAGR of 28%.
2. Profitability Metrics:
EBITDA improved from ₹13.1 Cr to ₹38 Cr with a CAGR of 62%, while PAT rose from ₹4.2 Cr to ₹11.3 Cr (CAGR 93%).
3. Margin Expansion:
Gross margins increased from 8.92% to 13.33%, and OPM remained stable above 6%, reflecting operational efficiencies.
4. EPS Movement:
EPS stood at ₹1.01 in FY24, rising from ₹0.82 in FY23, despite equity dilution.
5. Strong Asset Base:
Total assets grew from ₹220 Cr to ₹357 Cr, with fixed assets rising from ₹18.8 Cr to ₹47 Cr.
6. Borrowings & Leverage:
Borrowings increased from ₹123 Cr (FY22) to ₹216 Cr (FY24), funding aggressive expansion.
7. Capital Structure:
Share capital expanded from ₹5 Cr to ₹56.2 Cr, while reserves reached ₹32.6 Cr, indicating equity infusions to support growth.
Pros
- Stock is trading at 1.14 times its book value
- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 26.3%
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -6.23% over past five years.
- Company has a low return on equity of 3.68% over last 3 years.
Key Details
| Share Name | Particulars |
|---|---|
| Lord's Mark Industries Unlisted | 69.00 |
| Shares Price | Per Equity Share |
| Minimum Lot Size | Shares Worth Rs. 15000 |
| 52 Week High | ₹275 |
| 52 Week LoW | ₹125 |
| Depository | NSDL & CDSL |
| PAN Number | AAACL9328F |
| ISIN Number | INE0MPL01010 |
| CIN | U21000MH1998PTC115601 |
| RTA | Link Intime |
| Fundamentals | Value |
|---|---|
| Market Cap (in cr.) | 390.42 |
| P/E Ratio | 68.32 |
| P/B Ratio | 8.23 |
| Debt to Equity | 3.52 |
| ROE (%) | 12.73 |
| Book Value | 8.38 |
| EPS | 1.01 |
| Face Value | 5 |
| Total Shares | 56,582,108.00 |
Financials
| P&L Statement | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 555 | 305 | 213 |
| Cost of Material Consumed | 481 | 270 | 194 |
| Gross Margins | 13.33 | 11.48 | 8.92 |
| Change in Inventory | 0 | 0 | 0 |
| Employee Benefit Expenses | 17 | 6.6 | 1.8 |
| Other Expenses | 19 | 6.2 | 4.1 |
| EBITDA | 38 | 22.2 | 13.1 |
| OPM | 6.85 | 7.28 | 6.15 |
| Other Income | 1.5 | 0.8 | 0.9 |
| Finance Cost | 18.2 | 11.5 | 6 |
| D&A | 5 | 4.6 | 2.1 |
| EBIT | 33 | 17.6 | 11 |
| EBIT Margins | 5.95 | 5.77 | 5.16 |
| PBT | 15.5 | 6.4 | 5.5 |
| PBT Margins | 2.79 | 2.1 | 2.58 |
| Tax | 4.2 | 1.8 | 1.3 |
| PAT | 11.3 | 4.6 | 4.2 |
| NPM | 2.04 | 1.51 | 1.97 |
| EPS | 1.01 | 0.82 | 4.2 |
| Financial Ratios | FY23 | FY22 |
|---|---|---|
| Operating Margin | 6% | 5% |
| Net Profit Margin | 2% | 2% |
| Return on Equity | 12% | 13% |
| Debt-Equity | 3.52 | 1.89 |
| Current Ratio | 1.75 | 1.6 |
| Dividend Payout | 0% | 0% |
| Company | Lords Mark |
|---|---|
| Market Cap (₹ Crores) | 707 |
| Profitability Margin (%) | 2% |
| ROCE (%) | 16% |
| ROE (%) | 12% |
| D/E Ratio | 3.52 |
| P/E Ratio | 198.41 |
| P/B Ratio | 14.91 |
| Book Value per Share (₹) | 8.38 |
Promoters or Management
Annual Reports
| Name | Download |
|---|---|
| Lords Mark Report 2023 | View |
DRHP
Frequently Asked Questions
1. Has there been any recent investment in Lord’s Mark Industries?
Hindustan Media Ventures invested in Lord’s Mark shares by investing 31.22 crores to acquire share in it. This investment was made in the Lord’s Mark for the purpose of capital return in future with an aim to leverage media assets owned by the Company.
2. What are their plans for listing of share?
Lord's Mark Industries, an unlisted company with a presence in diagnostics, medtech, and renewable energy, is gearing up for a big move. The company is planning to go public through a reverse merger, and if all goes according to plan, it expects to be listed on the Bombay Stock Exchange (BSE) within the next 90 to 120 days. They've already cleared a major hurdle by getting SEBI's approval for the process.
Unlisted Market Blogs
Read the latest blogs and trends in the market regarding Unlisted shares